Celesio acquires Belgian wholesaler Laboratoria Flandria
Celesio has acquired the Belgian pharmaceutical wholesaler Laboratoria Flandria NV. The acquisition is an addition to the existing network of Celesio’s Belgian subsidiaries Pharma Belgium, Lloydspharma, Dirk Raes and pharmexx Belgium and will enable Celesio to offer new services.
“Laboratoria Flandria is a strong market player with state of the art facilities, a good reputation and a solid customer base. Together with our wholesaler Pharma Belgium we will achieve significant synergies which will further strengthen Celesio’s position in the Belgian pharmaceutical wholesale market”, Fritz Oesterle, CEO of Celesio, emphasises. The acquisition makes Celesio the second biggest pharmaceutical wholesaler in Belgium.
Celesio expects to utilise further synergies and to offer new services through the cooperation between the Celesio subsidiaries Pharma Belgium, Celesio’s pharmacy chain Lloydspharma, Dirk Raes, a provider of cold chain logistics for pharmaceutical manufacturers and pharmexx Belgium, a leading contract sales organisation for the pharmaceutical industry.
The acquisition of Laboratoria Flandria is subject to approval by the Belgian competition authority.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
BD Biosciences and StemCell Technologies Sign License Agreements with WARF - Commercialization of Novel Culture Media and Surfaces for Human Embryonic Stem Cell Research
Gellan_gum

Boys reach sexual maturity younger and younger - The phase between being physically but not socially adult is getting longer
Shire's Vyvanse Will Attain Blockbuster Status by 2017 in the Attention-Deficit/Hyperactivity Disorder Drug Market - Emerging Nonstimulant Drugs Will Earn Less Than 15 Percent Share of the ADHD Market in 2017, According to a New Report from Decision Resources
CellCept reaches positive results in Phase III trial in Lupus Nephritis
